Evercore ISI Group cuts Intuitive Surgical target to $430
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Intuitive Surgical (NASDAQ: ISRG) while lowering the price target to $430 from $480. The adjustment reflects a revised outlook on the stock's valuation.

*this image is generated using AI for illustrative purposes only.
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Intuitive Surgical (NASDAQ: ISRG) while lowering the price target to $430 from $480. The revised target reflects a recalibration of the stock's valuation expectations following recent market movements.
The decision to adjust the price target comes as the firm evaluates the company's current positioning within the medical technology sector. Despite the lower target, the In-Line rating suggests that the stock is expected to perform in line with the broader market averages.
Price Target Adjustment
The following table outlines the changes in the price target set by Evercore ISI Group:
| Metric | Previous Target | New Target |
|---|---|---|
| Price Target | $480 | $430 |
The reduction in the price target indicates a more conservative view on the stock's near-term potential. Investors should note that the In-Line rating implies no significant outperformance or underperformance relative to the market is anticipated at this time.
What specific market movements prompted Evercore ISI to recalibrate Intuitive Surgical's valuation?
How might this price target adjustment influence investor sentiment towards the medical technology sector?
What are the key factors that could drive Intuitive Surgical's performance in line with broader market averages?


























